Relating to informed consent for certain screening tests.

HB 50 requires healthcare providers to obtain patient consent before conducting blood screening tests for sexually transmitted diseases (STDs) and to inform patients they can opt out of the test. If a screening test is positive, providers must offer information about available healthcare, prevention, and support services. The bill applies to all medical screenings for STDs in Texas and takes effect January 1, 2026, after the Health and Human Services Commission adopts implementing rules. It does not change existing testing protocols but adds a consent requirement and post-positive support obligation for providers.